<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39469144</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Accumulated subcutaneous fat in abdomen is associated with long COVID-19 symptoms among non-hospitalized patients: a prospective observational study.</ArticleTitle><Pagination><StartPage>1410559</StartPage><MedlinePgn>1410559</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1410559</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2024.1410559</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Long COVID-19 symptoms may have a variety of potential overlapping causes. In this study, we aimed to investigate the potential correlation between abdominal adipose tissue and long COVID-19 symptoms in non-hospitalized patients in China.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This is a prospective observational study. 424 subjects, recovered from COVID-19 for 2-4 weeks, were enrolled and 408 subjects were finished the follow-up investigation at baseline, 8<sup>th</sup> week and 12<sup>th</sup> week. Physical measurements were collected. Kaplan-Meier analysis and cox regression analysis were carried out to assess the correlation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 72 subjects reported the long COVID-19 symptoms. The adjusted Kaplan-Meier analysis and Cox regression analysis revealed a significant correlation with accumulated subcutaneous fat (SFA &#x2265; 2.0 dm<sup>2</sup>) and the long COVID-19 symptoms (<i>HR</i> = 2.63, <i>P</i> &lt; 0.001 for male, <i>HR</i> = 1.52, P = 0.048 for female). However, overweight and central obesity showed positive correlation only in women.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">This study suggested that accumulated subcutaneous fat in abdomen (SFA &#x2265; 2.0 dm<sup>2</sup>) was an important positive factor associated with long COVID-19 symptoms among Chinese non-hospitalized patients. Large investigation and prospective studies are needed to validate the correlation in the future.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Li, He, Liu and Wang.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Tingxin</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Health Management Center and Institute of Health Management, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Baoming</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yuping</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Health Management Center and Institute of Health Management, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Ultrasound in Cardiac Electrophysiology and Biomechanics Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cardiovascular Disease, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiovascular Ultrasound and Noninvasive Cardiology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">non-hospitalized patients</Keyword><Keyword MajorTopicYN="N">subcutaneous fat</Keyword><Keyword MajorTopicYN="N">visceral fat</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>10</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>10</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>4</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39469144</ArticleId><ArticleId IdType="pmc">PMC11514070</ArticleId><ArticleId IdType="doi">10.3389/fmed.2024.1410559</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. Weekly operational update on COVID-19-May. Geneva: World Health Organization; (2022).</Citation></Reference><Reference><Citation>The Lancet Regional Health-Western Pacific. The end of zero-COVID-19 policy is not the end of COVID-19 for China. Lancet Reg Health West Pac. (2023) 30:100702. 10.1016/j.lanwpc.2023.100702</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanwpc.2023.100702</ArticleId><ArticleId IdType="pmc">PMC9887076</ArticleId><ArticleId IdType="pubmed">36741798</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y, Chen T, Liu L, Zong L. China ends its zero-COVID-19 policy: New challenges facing mental health services. Asian J Psychiatr. (2023) 82:103485. 10.1016/j.ajp.2023.103485</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajp.2023.103485</ArticleId><ArticleId IdType="pmc">PMC9888177</ArticleId><ArticleId IdType="pubmed">36731222</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. (2020) 324:603&#x2013;5. 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin S, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. (2021) 93:1013&#x2013;22. 10.1002/jmv.26368</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence. COVID-19 rapid guideline: Managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence; (2020).</Citation></Reference><Reference><Citation>Ballering A, van Zon S, Olde Hartman T, Rosmalen J. Persistence of somatic symptoms after COVID-19 in the Netherlands: An observational cohort study. Lancet. (2022) 400:452&#x2013;61. 10.1016/S0140-6736(22)01214-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe M, Caruso D, Tuccinardi D, Risi R, Zerunian M, Polici M, et al. Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19. Metabolism. (2020) 111:154319. 10.1016/j.metabol.2020.154319</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2020.154319</ArticleId><ArticleId IdType="pmc">PMC7377788</ArticleId><ArticleId IdType="pubmed">32712222</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen A, Bressem K, Albrecht J, Thie&#xdf; H, Vahldiek J, Hamm B, et al. The role of visceral adiposity in the severity of COVID-19: Highlights from a unicenter cross-sectional pilot study in Germany. Metabolism. (2020) 110:154317. 10.1016/j.metabol.2020.154317</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2020.154317</ArticleId><ArticleId IdType="pmc">PMC7358176</ArticleId><ArticleId IdType="pubmed">32673651</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed M, Moulin T, Schi&#xf6;th H. Sex differences in COVID-19: The role of androgens in disease severity and progression. Endocrine. (2021) 71:3&#x2013;8. 10.1007/s12020-020-02536-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02536-6</ArticleId><ArticleId IdType="pmc">PMC7657570</ArticleId><ArticleId IdType="pubmed">33179220</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long Covid-mechanisms, risk factors, and management. BMJ. (2021) 374:n1648. 10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui L, Lee Y, Gill H, Teopiz K, et al. Fatigue and cognitive impairment in post-COVID-19 syndrome: A systematic review and meta-analysis. Brain Behav Immun. (2022) 101:93&#x2013;35. 10.1016/j.bbi.2021.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P, Liu J, Liu M. Effect of COVID-19 vaccines on reducing the risk of long COVID in the real world: A systematic review and meta-analysis. Int J Environ Res Public Health. (2022) 19:12422. 10.3390/ijerph191912422</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912422</ArticleId><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Islas D, Flores-Cisneros L, Orea-Tejeda A, Keirns-Davis C, Hern&#xe1;ndez-L&#xf3;pez N, Arcos-Pacheco L, et al. The association between body composition phenotype and insulin resistance in post-COVID-19 syndrome patients without diabetes: A cross-sectional, single-center study. Nutrients. (2024) 16:2468. 10.3390/nu16152468</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu16152468</ArticleId><ArticleId IdType="pmc">PMC11314085</ArticleId><ArticleId IdType="pubmed">39125348</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill S, Brown J, Denneny E, Hare S, et al. &#x2019;Long-COVID&#x2019;: A cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. (2021) 76:396&#x2013;8. 10.1136/thoraxjnl-2020-215818</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrea L, Verde L, Grant W, Frias-Toral E, Sarno G, Vetrani C, et al. Vitamin D: A role also in long COVID-19? Nutrients. (2022) 14:1625. 10.3390/nu14081625</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14081625</ArticleId><ArticleId IdType="pmc">PMC9028162</ArticleId><ArticleId IdType="pubmed">35458189</ArticleId></ArticleIdList></Reference><Reference><Citation>Paneroni M, Simonelli C, Saleri M, Bertacchini L, Venturelli M, Troosters T, et al. Muscle strength and physical performance in patients without previous disabilities recovering from COVID-19 pneumonia. Am J Phys Med Rehabil. (2021) 100: 105&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">33181531</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes D, Holdsworth L, Jawad N, Gunasekera P, Morice A, Crooks M. Post-COVID-19 symptom burden: What is long-COVID and how should we manage it? Lung. (2021) 199:113&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H, McCorkell L, Vogel J, Topol E. Long COVID: Major findings, mechanisms and recommendations. Nat Rev Microbiol. (2023) 21:133&#x2013;46. 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Park K, Lee D, Lee J, Kim Y, Jung K, Kim K, et al. Comparison between two methods of bioelectrical impedance analyses for accuracy in measuring abdominal visceral fat area. J Diabetes Complications. (2016) 30:343&#x2013;9. 10.1016/j.jdiacomp.2015.10.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdiacomp.2015.10.014</ArticleId><ArticleId IdType="pubmed">26620129</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D, Park K, Ahn S, Ku E, Jung K, Kim Y, et al. Comparison of abdominal visceral adipose tissue area measured by computed tomography with that estimated by bioelectrical impedance analysis method in Korean subjects. Nutrients. (2015) 7:10513&#x2013;24. 10.3390/nu7125548</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu7125548</ArticleId><ArticleId IdType="pmc">PMC4690100</ArticleId><ArticleId IdType="pubmed">26694460</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamasaki H, Furuta M, Yanai H. Validity of visceral fat area measurement by bioelectrical impedance analysis in japanese obese individuals. Curr Diabetes Rev. (2020) 16:515&#x2013;9. 10.2174/1573399815666190128113657</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1573399815666190128113657</ArticleId><ArticleId IdType="pubmed">30686247</ArticleId></ArticleIdList></Reference><Reference><Citation>Gra&#xdf;mann S, Wirsching J, Eichelmann F, Aleksandrova K. Association between peripheral adipokines and inflammation markers: A systematic review and meta-analysis. Obesity (Silver Spring). (2017) 25:1776&#x2013;85. 10.1002/oby.21945</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oby.21945</ArticleId><ArticleId IdType="pubmed">28834421</ArticleId></ArticleIdList></Reference><Reference><Citation>De Nooijer A, Kooistra E, Grondman I, Janssen N, Joosten L, van de Veerdonk F, et al. Adipocytokine plasma concentrations reflect influence of inflammation but not body mass index (BMI) on clinical outcomes of COVID-19 patients: A prospective observational study from the Netherlands. Clin Obes. (2023) 13:e12568.</Citation><ArticleIdList><ArticleId IdType="pubmed">36426776</ArticleId></ArticleIdList></Reference><Reference><Citation>Korac A, Srdic-Galic B, Kalezic A, Stancic A, Otasevic V, Korac B, et al. Adipokine signatures of subcutaneous and visceral abdominal fat in normal-weight and obese women with different metabolic profiles. Arch Med Sci. (2021) 17:323&#x2013;36. 10.5114/aoms/92118</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/aoms/92118</ArticleId><ArticleId IdType="pmc">PMC7959090</ArticleId><ArticleId IdType="pubmed">33747267</ArticleId></ArticleIdList></Reference><Reference><Citation>Bu J, Feng Q, Ran J, Li Q, Mei G, Zhang Y. Visceral fat mass is always, but adipokines (adiponectin and resistin) are diversely associated with insulin resistance in Chinese type 2 diabetic and normoglycemic subjects. Diabetes Res Clin Pract. (2012) 96:163&#x2013;9. 10.1016/j.diabres.2011.12.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2011.12.014</ArticleId><ArticleId IdType="pubmed">22244787</ArticleId></ArticleIdList></Reference><Reference><Citation>Gugliucci A. Biomarkers of dysfunctional visceral fat. Adv Clin Chem. (2022) 109:1&#x2013;30. 10.1016/bs.acc.2022.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.acc.2022.03.001</ArticleId><ArticleId IdType="pubmed">35953124</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, Shin M, Lee Y, Choi S, Nam H, Yang J, et al. Comparative analysis of body mass index and obesity-related anthropometric indices for mortality prediction: A study of the Namwon and Dong-Gu cohorts. Epidemiol Health. (2024) 17:e2024066. 10.4178/epih.e2024066</Citation><ArticleIdList><ArticleId IdType="doi">10.4178/epih.e2024066</ArticleId><ArticleId IdType="pubmed">39054626</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhlaq S, Khaliq S. Normoglycemia and type 2 diabetes: Exploring secreted frizzled-4, insulin resistance, and waist-height ratio. J Pak Med Assoc. (2024) 74:1338&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">39028066</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Su H, Gong Y, Chen L, Xu L, Chen G, et al. The association between weight-adjusted-waist index and sarcopenia in adults: A population-based study. Sci Rep. (2024) 14:10943. 10.1038/s41598-024-61928-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-61928-0</ArticleId><ArticleId IdType="pmc">PMC11091224</ArticleId><ArticleId IdType="pubmed">38740910</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng C, Ke X, Guo X. Investigating a novel surrogate indicator of adipose accumulation in relation to erectile dysfunction. Lipids Health Dis. (2024) 23:139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11089710</ArticleId><ArticleId IdType="pubmed">38741154</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayawardena R, Sooriyaarachchi P, Misra A. Abdominal obesity and metabolic syndrome in South Asians: Prevention and management. Expert Rev Endocrinol Metab. (2021) 16:339&#x2013;49. 10.1080/17446651.2021.1982381</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17446651.2021.1982381</ArticleId><ArticleId IdType="pubmed">34586004</ArticleId></ArticleIdList></Reference><Reference><Citation>Navaneethan S, Kirwan J, Remer E, Schneider E, Addeman B, Arrigain S, et al. Adiposity, physical function, and their associations with insulin resistance, inflammation, and adipokines in CKD. Am J Kidney Dis. (2021) 77:44&#x2013;55. 10.1053/j.ajkd.2020.05.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2020.05.028</ArticleId><ArticleId IdType="pmc">PMC7752817</ArticleId><ArticleId IdType="pubmed">32798563</ArticleId></ArticleIdList></Reference><Reference><Citation>Lind L, Strand R, Kullberg J, Ahlstr&#xf6;m H. Cardiovascular-related proteins and the abdominal visceral to subcutaneous adipose tissue ratio. Nutr Metab Cardiovasc Dis. (2021) 31:532&#x2013;9. 10.1016/j.numecd.2020.09.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.numecd.2020.09.010</ArticleId><ArticleId IdType="pubmed">33153859</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Somers K, Becari C, Polonis K, Pfeifer M, Allen A, et al. comparative expression of renin-angiotensin pathway proteins in visceral versus subcutaneous fat. Front Physiol. (2018) 9:1370. 10.3389/fphys.2018.01370</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.01370</ArticleId><ArticleId IdType="pmc">PMC6191467</ArticleId><ArticleId IdType="pubmed">30364113</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaduganathan M, Vardeny O, Michel T, McMurray J, Pfeffer M, Solomon S. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med. (2020) 382:1653&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7121452</ArticleId><ArticleId IdType="pubmed">32227760</ArticleId></ArticleIdList></Reference><Reference><Citation>Favre G, Legueult K, Pradier C, Raffaelli C, Ichai C, Iannelli A, et al. Visceral fat is associated to the severity of COVID-19. Metabolism. (2021) 115:154440. 10.1016/j.metabol.2020.154440</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2020.154440</ArticleId><ArticleId IdType="pmc">PMC7685947</ArticleId><ArticleId IdType="pubmed">33246009</ArticleId></ArticleIdList></Reference><Reference><Citation>Devaux C, Rolain J, Raoult D. ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. J Microbiol Immunol Infect. (2020) 53:425&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7201239</ArticleId><ArticleId IdType="pubmed">32414646</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds H, Adhikari S, Pulgarin C, Troxel A, Iturrate E, Johnson S, et al. Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19. N Engl J Med. (2020) 382:2441&#x2013;8. 10.1056/NEJMoa2008975</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2008975</ArticleId><ArticleId IdType="pmc">PMC7206932</ArticleId><ArticleId IdType="pubmed">32356628</ArticleId></ArticleIdList></Reference><Reference><Citation>Braga-Paz I, Ferreira de Ara&#xfa;jo JL, Alves HJ, de &#xc1;vila RE, Resende GG, Teixeira MM, et al. Negative correlation between ACE2 gene expression levels and loss of taste in a cohort of COVID-19 hospitalized patients: New clues to long-term cognitive disorders. Front Cell Infect Microbiol. (2022) 12:905757. 10.3389/fcimb.2022.905757</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.905757</ArticleId><ArticleId IdType="pmc">PMC9556632</ArticleId><ArticleId IdType="pubmed">36250059</ArticleId></ArticleIdList></Reference><Reference><Citation>Safari S, Keyvani H, Malekpour Alamdari N, Dehghanian A, Razavi Hashemi M, Nemati Honar B, et al. Abdominal surgery in patients with COVID-19: Detection of SARS-CoV-2 in abdominal and adipose tissues. Ann Surg. (2020) 272:e253&#x2013;6. 10.1097/SLA.0000000000004165</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000004165</ArticleId><ArticleId IdType="pmc">PMC7467038</ArticleId><ArticleId IdType="pubmed">32568751</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>